Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Barclays price target raised to 230 GBp from 210 GBp at JPMorgan » 07:32
06/16/21
06/16
07:32
06/16/21
07:32
BCS

Barclays

$10.26 /

+0.01 (+0.10%)

JPMorgan analyst Kian…

JPMorgan analyst Kian Abouhossein raised the firm's price target on Barclays to 230 GBp from 210 GBp and keeps an Overweight rating on the shares. The investment banking industry "is in a much better shape today compared to where it has ever been" due to the transformation to a more sustainable, lower capital intensive business, focus on captive sustainable revenue streams and higher barriers of entry, Abouhossein tells investors in a research note. The analyst believes the industry is "well positioned for undiscounted growth." The growth outlook and reduced risk profile, combined with the high barriers of entry in the business, should enable "Tier I" investment banking businesses to command a higher price-to-earnings multiple both absolute and relative compared to retail banking, contends Abouhossein.

ShowHide Related Items >><<
BCS Barclays
$10.26 /

+0.01 (+0.10%)

BCS Barclays
$10.26 /

+0.01 (+0.10%)

06/07/21 Morgan Stanley
Barclays price target raised to 200 GBp from 190 GBp at Morgan Stanley
05/05/21 Berenberg
Barclays price target raised to 220 GBp from 180 GBp at Berenberg
05/04/21 Societe Generale
Barclays price target raised to 170 GBp from 150 GBp at Societe Generale
05/04/21 Investec
Barclays upgraded to Buy from Hold at Investec
BCS Barclays
$10.26 /

+0.01 (+0.10%)

BCS Barclays
$10.26 /

+0.01 (+0.10%)

BCS Barclays
$10.26 /

+0.01 (+0.10%)

BCS Barclays
$10.26 /

+0.01 (+0.10%)

Tuesday
Recommendations
Global Net Lease price target raised to $24 from $23 at B. Riley » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
GNL

Global Net Lease

$19.98 /

+0.18 (+0.91%)

B. Riley analyst Bryan…

B. Riley analyst Bryan Maher raised the firm's price target on Global Net Lease to $24 from $23 and keeps a Buy rating on the shares. The general impression coming out of NAREIT's REITweek is that real estate investment trusts are mostly optimistic about current economic and business trends as we move further into the recovery from the Covid-19 pandemic, the analyst tells investors in a research note.

ShowHide Related Items >><<
GNL Global Net Lease
$19.98 /

+0.18 (+0.91%)

GNL Global Net Lease
$19.98 /

+0.18 (+0.91%)

03/01/21 B. Riley
Global Net Lease price target raised to $23 from $21 at B. Riley Securities
09/22/20 Ladenburg
Ladenburg stays Neutral on Global Net Lease due to growth headwinds
06/30/20 Berenberg
Global Net Lease initiated with a Buy at Berenberg
Monday
On The Fly
Wall Street in Fives - Must Read Lists for Monday » 16:07
06/14/21
06/14
16:07
06/14/21
16:07
RDS.A

Royal Dutch Shell

$41.18 /

+0.765 (+1.89%)

, RDS.B

Royal Dutch Shell

$39.02 /

+0.775 (+2.03%)

, NVAX

Novavax

$208.17 /

-1.43 (-0.68%)

, MRNA

Moderna

$206.41 /

-12.39 (-5.66%)

, RIDE

Lordstown Motors

$9.19 /

-2.215 (-19.43%)

, TSLA

Tesla

$616.40 /

+6.48 (+1.06%)

, WPG

Washington Prime

$3.35 /

-1.49 (-30.79%)

, CMG

Chipotle

$1,391.53 /

+24.24 (+1.77%)

, CRSP

Crispr Therapeutics

$128.44 /

+1.36 (+1.07%)

, OTLY

Oatly Group

$27.53 /

-1.18 (-4.11%)

, CLB

Core Laboratories

$45.25 /

-2.46 (-5.16%)

, AVB

AvalonBay

$213.71 /

-0.78 (-0.36%)

, VIVHY

Vivendi

$35.46 /

+0.39 (+1.11%)

, NGAC

NextGen Acquisition Corp.

$9.98 /

-0.02 (-0.20%)

, GSK

GlaxoSmithKline

$40.41 /

+0.26 (+0.65%)

, WOOF

Petco

$28.21 /

+4.4 (+18.48%)

, RAPT

Rapt Therapeutics

$40.40 /

+21.805 (+117.26%)

, ITOS

iTeos Therapeutics

$27.50 /

+7.5 (+37.50%)

, BTX

Brooklyn ImmunoTherapeutics

$15.16 /

+0.705 (+4.88%)

, ENDP

Endo

$5.63 /

-0.62 (-9.92%)

, FBIO

Fortress Biotech

$3.80 /

-0.69 (-15.37%)

, ATXI

Avenue Therapeutics

$2.95 /

-1.285 (-30.38%)

, MPAA

Motorcar Parts

$24.13 /

+0.89 (+3.83%)

, KLR

Kaleyra

$11.79 /

-0.61 (-4.92%)

, CANO

Cano Health

$14.80 /

+0.075 (+0.51%)

, CODA

Coda Octopus

$9.90 /

+0.75 (+8.20%)

, DUK

Duke Energy

$102.35 /

+0.42 (+0.41%)

, BTC

Bitcoin

$0.00 /

+ (+0.00%)

, BITCOIN

Bitcoin

/

+

, $BTC

Bitcoin

$0.00 /

+ (+0.00%)

Get caught up quickly on…

ShowHide Related Items >><<
WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

RAPT Rapt Therapeutics
$40.40 /

+21.805 (+117.26%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

MPAA Motorcar Parts
$24.13 /

+0.89 (+3.83%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

ITOS iTeos Therapeutics
$27.50 /

+7.5 (+37.50%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

CANO Cano Health
$14.80 /

+0.075 (+0.51%)

BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
/

+

AVB AvalonBay
$213.71 /

-0.78 (-0.36%)

ATXI Avenue Therapeutics
$2.95 /

-1.285 (-30.38%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

06/08/21 DZ Bank
Royal Dutch Shell downgraded to Hold from Buy at DZ Bank
05/17/21 Mizuho
Royal Dutch Shell price target raised to $61 from $56 at Mizuho
04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
NVAX Novavax
$208.17 /

-1.43 (-0.68%)

06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
05/12/21 Cantor Fitzgerald
Novavax price target lowered to $217 from $338 at Cantor Fitzgerald
MRNA Moderna
$206.41 /

-12.39 (-5.66%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

06/14/21 Morgan Stanley
Lordstown management change 'important first step,' says Morgan Stanley
06/14/21 R.F. Lafferty
R.F. Lafferty downgrades Lordstown to Sell with $3 target on uncertainty
06/14/21 R.F. Lafferty
Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
TSLA Tesla
$616.40 /

+6.48 (+1.06%)

06/14/21 Canaccord
Tesla price target lowered to $812 from $974 at Canaccord
06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

04/06/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
04/05/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
02/16/21 Truist
Washington Prime coupon non-payment part of negotiating process, says Truist
02/01/21 Truist
Macerich Q4 results 'weak,' but not much worse than expected, says Truist
CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Wells Fargo
Chipotle price target lowered to $1,720 from $1,818 at Wells Fargo
06/14/21 Raymond James
Raymond James upgrades Chipotle to Strong Buy on menu price hikes
06/14/21 Raymond James
Chipotle upgraded to Strong Buy from Outperform at Raymond James
CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

06/14/21 Citi
Crispr Therapeutics upgraded to Neutral from Sell at Citi
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Jefferies
Oatly Group initiated with a Buy at Jefferies
06/14/21 JPMorgan
Oatly Group initiated with a Neutral at JPMorgan
06/14/21 Truist
Oatly Group initiated with a Buy at Truist
CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

06/14/21
Fly Intel: Top five analyst downgrades
06/14/21 Citi
Core Laboratories downgraded to Sell from Neutral at Citi
04/23/21 Citi
Core Laboratories price target lowered to $30 from $36 at Citi
01/11/21 Wolfe Research
Core Laboratories upgraded to Peer Perform from Underperform at Wolfe Research
AVB AvalonBay
$213.71 /

-0.78 (-0.36%)

06/14/21 Evercore ISI
AvalonBay downgraded to In Line from Outperform at Evercore ISI
06/11/21 Morgan Stanley
AvalonBay price target raised to $218 from $210 at Morgan Stanley
06/04/21 Truist
AvalonBay downgraded to Hold from Buy at Truist on premium valuation
VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

06/01/21
Fly Intel: Top five analyst downgrades
06/01/21 Bernstein
Vivendi downgraded to Market Perform from Outperform at Bernstein
05/14/21 Credit Suisse
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse
04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

06/11/21 Benchmark
NextGen Acquisition Corp. initiated with a Buy at Benchmark
GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
WOOF Petco
$28.21 /

+4.4 (+18.48%)

06/02/21
Fly Intel: Top five analyst initiations
06/02/21 Citi
Petco reinstated with a Buy at Citi
05/21/21 Baird
Petco weakness a buying opportunity, says at Baird
05/20/21 Baird
Petco pullback a buying opportunity, says Baird
RAPT Rapt Therapeutics
$40.40 /

+21.805 (+117.26%)

06/14/21 Wells Fargo
Rapt Therapeutics price target raised to $65 from $30 at Wells Fargo
06/14/21 Roth Capital
Rapt Therapeutics price target raised to $72 from $38 at Roth Capital
06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
ITOS iTeos Therapeutics
$27.50 /

+7.5 (+37.50%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

05/17/21 Citi
Endo price target raised to $11 from $10 at Citi
04/06/21 RBC Capital
Endo transferred with a Sector Perform at RBC Capital
03/08/21 Barclays
Endo price target raised to $7 from $6 at Barclays
03/04/21 Citi
Endo price target lowered to $10 from $11 at Citi
FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
04/05/21 B. Riley
Fortress Biotech price target raised to $9 from $8 at B. Riley
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
12/14/20 Benchmark
Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
ATXI Avenue Therapeutics
$2.95 /

-1.285 (-30.38%)

03/01/21 H.C. Wainwright
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
MPAA Motorcar Parts
$24.13 /

+0.89 (+3.83%)

02/04/21 B. Riley
Motorcar Parts price target raised to $28 from $25 at B. Riley Securities
08/11/20 Craig-Hallum
Motorcar Parts downgraded to Hold from Buy at Craig-Hallum
07/01/20 B. Riley
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
02/22/21 Maxim
Kaleyra price target raised to $42 from $30 at Maxim
02/17/21 Craig-Hallum
Kaleyra price target raised to $25 from $20 at Craig-Hallum
CANO Cano Health
$14.80 /

+0.075 (+0.51%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
CODA Coda Octopus
$9.90 /

+0.75 (+8.20%)

06/14/21 Alliance Global Partners
Coda Octopus price target raised to $13 from $11 at Alliance Global
DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
05/12/21 Mizuho
Duke Energy price target raised to $105 from $96 at Mizuho
04/14/21 Credit Suisse
Duke Energy price target raised to $104 from $96 at Credit Suisse
04/14/21 Wells Fargo
Duke Energy price target raised to $104 from $97 at Wells Fargo
BTC Bitcoin
$0.00 /

+ (+0.00%)

04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
$BTC Bitcoin
$0.00 /

+ (+0.00%)

WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

RAPT Rapt Therapeutics
$40.40 /

+21.805 (+117.26%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

MPAA Motorcar Parts
$24.13 /

+0.89 (+3.83%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

ITOS iTeos Therapeutics
$27.50 /

+7.5 (+37.50%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CODA Coda Octopus
$9.90 /

+0.75 (+8.20%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

CANO Cano Health
$14.80 /

+0.075 (+0.51%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

AVB AvalonBay
$213.71 /

-0.78 (-0.36%)

  • 27
    May
  • 20
    May
  • 14
    Jan
  • 24
    Jul
  • 01
    Jul
  • 25
    Jun
WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

VIVHY Vivendi
$35.46 /

+0.39 (+1.11%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

RDS.B Royal Dutch Shell
$39.02 /

+0.775 (+2.03%)

RDS.A Royal Dutch Shell
$41.18 /

+0.765 (+1.89%)

OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

DUK Duke Energy
$102.35 /

+0.42 (+0.41%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CLB Core Laboratories
$45.25 /

-2.46 (-5.16%)

BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

ATXI Avenue Therapeutics
$2.95 /

-1.285 (-30.38%)

WPG Washington Prime
$3.35 /

-1.49 (-30.79%)

WOOF Petco
$28.21 /

+4.4 (+18.48%)

TSLA Tesla
$616.40 /

+6.48 (+1.06%)

RIDE Lordstown Motors
$9.19 /

-2.215 (-19.43%)

OTLY Oatly Group
$27.53 /

-1.18 (-4.11%)

NVAX Novavax
$208.17 /

-1.43 (-0.68%)

NGAC NextGen Acquisition Corp.
$9.98 /

-0.02 (-0.20%)

MRNA Moderna
$206.41 /

-12.39 (-5.66%)

KLR Kaleyra
$11.79 /

-0.61 (-4.92%)

GSK GlaxoSmithKline
$40.41 /

+0.26 (+0.65%)

FBIO Fortress Biotech
$3.80 /

-0.69 (-15.37%)

ENDP Endo
$5.63 /

-0.62 (-9.92%)

CRSP Crispr Therapeutics
$128.44 /

+1.36 (+1.07%)

CMG Chipotle
$1,391.53 /

+24.24 (+1.77%)

CANO Cano Health
$14.80 /

+0.075 (+0.51%)

BTX Brooklyn ImmunoTherapeutics
$15.16 /

+0.705 (+4.88%)

Options
GlaxoSmithKline call volume above normal and directionally bullish » 14:05
06/14/21
06/14
14:05
06/14/21
14:05
GSK

GlaxoSmithKline

$40.26 /

+0.11 (+0.27%)

Bullish option flow…

Bullish option flow detected in GlaxoSmithKline with 13,764 calls trading, 5x expected, and implied vol increasing over 5 points to 22.95%. 6/25 weekly 41 calls and 7/2 weekly 41 calls are the most active options, with total volume in those strikes near 7,000 contracts. The Put/Call Ratio is 0.05. Earnings are expected on July 28th.

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.26 /

+0.11 (+0.27%)

GSK GlaxoSmithKline
$40.26 /

+0.11 (+0.27%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
GSK GlaxoSmithKline
$40.26 /

+0.11 (+0.27%)

GSK GlaxoSmithKline
$40.26 /

+0.11 (+0.27%)

GSK GlaxoSmithKline
$40.26 /

+0.11 (+0.27%)

GSK GlaxoSmithKline
$40.26 /

+0.11 (+0.27%)

Hot Stocks
BAE Systems receives $90.2M contract from U.S. Navy » 14:00
06/14/21
06/14
14:00
06/14/21
14:00
BAESY

BAE Systems

$30.62 /

+0.09 (+0.29%)

BAE Systems has received…

BAE Systems has received a $90.2M contract from the U.S. Navy for the maintenance and modernization of the amphibious transport dock USS San Diego. The value of the competitively awarded contract could reach $104.8M if all options are exercised. Under the docking selected restricted availability contract awarded, BAE Systems will dry-dock the 684-foot-long ship, perform work on the underwater hull, repair its system of ballast tanks, preserve its amphibious well deck area, and refurbish the living spaces for as many as 800 sailors and Marines that can be carried aboard. The work is expected to begin in September 2021 at the company's San Diego shipyard and take more than a year to complete.

ShowHide Related Items >><<
BAESY BAE Systems
$30.62 /

+0.09 (+0.29%)

BAESY BAE Systems
$30.62 /

+0.09 (+0.29%)

05/25/21 Societe Generale
BAE Systems price target raised to 614 GBp from 606 GBp at Societe Generale
04/14/21 Morgan Stanley
BAE Systems price target lowered to 640 GBp from 647 GBp at Morgan Stanley
04/09/21 Exane BNP Paribas
BAE Systems downgraded to Neutral from Outperform at Exane BNP Paribas
03/30/21 Bernstein
BAE Systems upgraded to Outperform from Market Perform at Bernstein
BAESY BAE Systems
$30.62 /

+0.09 (+0.29%)

BAESY BAE Systems
$30.62 /

+0.09 (+0.29%)

Recommendations
Siemens Healthineers price target raised to EUR 48 from EUR 46 at UBS » 12:22
06/14/21
06/14
12:22
06/14/21
12:22
SMMNY

Siemens Healthineers

$29.28 /

+0.31 (+1.07%)

UBS analyst Thando…

UBS analyst Thando Skosana raised the firm's price target on Siemens Healthineers to EUR 48 from EUR 46 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$29.28 /

+0.31 (+1.07%)

05/04/21 JPMorgan
Siemens Healthineers price target lowered to EUR 54.40 at JPMorgan
05/04/21 Credit Suisse
Siemens Healthineers price target raised to EUR 55 from EUR 54 at Credit Suisse
05/04/21 Deutsche Bank
Siemens Healthineers upgraded to Buy from Hold at Deutsche Bank
04/30/21 Barclays
Siemens Healthineers price target raised to EUR 47 from EUR 41 at Barclays
SMMNY Siemens Healthineers
$29.28 /

+0.31 (+1.07%)

SMMNY Siemens Healthineers
$29.28 /

+0.31 (+1.07%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:02
06/14/21
06/14
12:02
06/14/21
12:02
NVAX

Novavax

$203.46 /

-6.14 (-2.93%)

, MRNA

Moderna

$205.25 /

-13.55 (-6.19%)

, RIDE

Lordstown Motors

$9.39 /

-2.01 (-17.63%)

, TSLA

Tesla

$616.70 /

+6.78 (+1.11%)

, WPG

Washington Prime

$3.71 /

-1.135 (-23.45%)

, CMG

Chipotle

$1,393.00 /

+25.71 (+1.88%)

, OTLY

Oatly Group

$27.64 /

-1.07 (-3.73%)

, CRSP

Crispr Therapeutics

$128.47 /

+1.39 (+1.09%)

, CLB

Core Laboratories

$47.61 /

-0.1 (-0.21%)

, AVB

AvalonBay

$212.92 /

-1.57 (-0.73%)

, VIVHY

Vivendi

$35.07 /

-0.13 (-0.37%)

, NGAC

NextGen Acquisition Corp.

$10.01 /

+0.01 (+0.10%)

, GSK

GlaxoSmithKline

$40.32 /

+0.17 (+0.42%)

, GS

Goldman Sachs

$373.62 /

-4.4 (-1.16%)

, RDS.A

Royal Dutch Shell

$41.47 /

+1.055 (+2.61%)

, RDS.B

Royal Dutch Shell

$39.26 /

+1.015 (+2.65%)

, RAPT

Rapt Therapeutics

$38.82 /

+20.225 (+108.77%)

, ITOS

iTeos Therapeutics

$27.55 /

+7.55 (+37.75%)

, BTX

Brooklyn ImmunoTherapeutics

$15.49 /

+1.04 (+7.20%)

, ENDP

Endo

$5.79 /

-0.46 (-7.36%)

, FBIO

Fortress Biotech

$3.94 /

-0.55 (-12.25%)

, BITCOIN

Bitcoin

/

+

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

, MPAA

Motorcar Parts

$24.61 /

+1.37 (+5.90%)

, KLR

Kaleyra

$11.80 /

-0.6 (-4.84%)

, CANO

Cano Health

$15.02 /

+0.295 (+2.00%)

, CODA

Coda Octopus Group

$9.73 /

+0.58 (+6.34%)

, DUK

Duke Energy

$101.94 /

+0.01 (+0.01%)

1. STOCK NEWS: …

ShowHide Related Items >><<
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

RAPT Rapt Therapeutics
$38.82 /

+20.225 (+108.77%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

MPAA Motorcar Parts
$24.61 /

+1.37 (+5.90%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

ITOS iTeos Therapeutics
$27.55 /

+7.55 (+37.75%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

CANO Cano Health
$15.02 /

+0.295 (+2.00%)

BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

AVB AvalonBay
$212.92 /

-1.57 (-0.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
05/12/21 Cantor Fitzgerald
Novavax price target lowered to $217 from $338 at Cantor Fitzgerald
MRNA Moderna
$205.25 /

-13.55 (-6.19%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

06/14/21 R.F. Lafferty
R.F. Lafferty downgrades Lordstown to Sell with $3 target on uncertainty
06/14/21 R.F. Lafferty
Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
06/08/21 RBC Capital
Lordstown Motors initiated with an Underperform at RBC Capital
TSLA Tesla
$616.70 /

+6.78 (+1.11%)

06/14/21 Canaccord
Tesla price target lowered to $812 from $974 at Canaccord
06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

04/06/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
04/05/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
02/16/21 Truist
Washington Prime coupon non-payment part of negotiating process, says Truist
02/01/21 Truist
Macerich Q4 results 'weak,' but not much worse than expected, says Truist
CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Wells Fargo
Chipotle price target lowered to $1,720 from $1,818 at Wells Fargo
06/14/21 Raymond James
Raymond James upgrades Chipotle to Strong Buy on menu price hikes
06/14/21 Raymond James
Chipotle upgraded to Strong Buy from Outperform at Raymond James
OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Jefferies
Oatly Group initiated with a Buy at Jefferies
06/14/21 JPMorgan
Oatly Group initiated with a Neutral at JPMorgan
06/14/21 Truist
Oatly Group initiated with a Buy at Truist
CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

06/14/21 Citi
Crispr Therapeutics upgraded to Neutral from Sell at Citi
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

06/14/21
Fly Intel: Top five analyst downgrades
06/14/21 Citi
Core Laboratories downgraded to Sell from Neutral at Citi
04/23/21 Citi
Core Laboratories price target lowered to $30 from $36 at Citi
01/11/21 Wolfe Research
Core Laboratories upgraded to Peer Perform from Underperform at Wolfe Research
AVB AvalonBay
$212.92 /

-1.57 (-0.73%)

06/14/21 Evercore ISI
AvalonBay downgraded to In Line from Outperform at Evercore ISI
06/11/21 Morgan Stanley
AvalonBay price target raised to $218 from $210 at Morgan Stanley
06/04/21 Truist
AvalonBay downgraded to Hold from Buy at Truist on premium valuation
VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

06/01/21
Fly Intel: Top five analyst downgrades
06/01/21 Bernstein
Vivendi downgraded to Market Perform from Outperform at Bernstein
05/14/21 Credit Suisse
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse
04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

06/11/21 Benchmark
NextGen Acquisition Corp. initiated with a Buy at Benchmark
GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

06/09/21 Jefferies
Jefferies starts 'too cheap' Goldman Sachs at Buy
06/09/21 Jefferies
Goldman Sachs initiated with a Buy at Jefferies
06/01/21 Piper Sandler
Goldman Sachs price target raised to $420 from $385 at Piper Sandler
05/12/21 Wells Fargo
Summer travel should be catalyst for commercial aero, says Wells Fargo
RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

06/08/21 DZ Bank
Royal Dutch Shell downgraded to Hold from Buy at DZ Bank
05/17/21 Mizuho
Royal Dutch Shell price target raised to $61 from $56 at Mizuho
04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
RAPT Rapt Therapeutics
$38.82 /

+20.225 (+108.77%)

06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
04/12/21 Roth Capital
Roth says Rapt Therapeutics' AACR presentations highlight broad potential
ITOS iTeos Therapeutics
$27.55 /

+7.55 (+37.75%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

05/17/21 Citi
Endo price target raised to $11 from $10 at Citi
04/06/21 RBC Capital
Endo transferred with a Sector Perform at RBC Capital
03/08/21 Barclays
Endo price target raised to $7 from $6 at Barclays
03/04/21 Citi
Endo price target lowered to $10 from $11 at Citi
FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
04/05/21 B. Riley
Fortress Biotech price target raised to $9 from $8 at B. Riley
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
12/14/20 Benchmark
Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
BTC Bitcoin
/

+

01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
$BTC Bitcoin
/

+

MPAA Motorcar Parts
$24.61 /

+1.37 (+5.90%)

02/04/21 B. Riley
Motorcar Parts price target raised to $28 from $25 at B. Riley Securities
08/11/20 Craig-Hallum
Motorcar Parts downgraded to Hold from Buy at Craig-Hallum
07/01/20 B. Riley
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
02/22/21 Maxim
Kaleyra price target raised to $42 from $30 at Maxim
02/17/21 Craig-Hallum
Kaleyra price target raised to $25 from $20 at Craig-Hallum
CANO Cano Health
$15.02 /

+0.295 (+2.00%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
CODA Coda Octopus Group
$9.73 /

+0.58 (+6.34%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
05/12/21 Mizuho
Duke Energy price target raised to $105 from $96 at Mizuho
04/14/21 Credit Suisse
Duke Energy price target raised to $104 from $96 at Credit Suisse
04/14/21 Wells Fargo
Duke Energy price target raised to $104 from $97 at Wells Fargo
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

RAPT Rapt Therapeutics
$38.82 /

+20.225 (+108.77%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

MPAA Motorcar Parts
$24.61 /

+1.37 (+5.90%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

ITOS iTeos Therapeutics
$27.55 /

+7.55 (+37.75%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CODA Coda Octopus Group
$9.73 /

+0.58 (+6.34%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

CANO Cano Health
$15.02 /

+0.295 (+2.00%)

BITCOIN Bitcoin
/

+

AVB AvalonBay
$212.92 /

-1.57 (-0.73%)

  • 20
    May
  • 24
    Jul
  • 01
    Jul
  • 25
    Jun
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

BITCOIN Bitcoin
/

+

VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

BITCOIN Bitcoin
/

+

WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CANO Cano Health
$15.02 /

+0.295 (+2.00%)

BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

Conference/Events
Zebra Technologies participates in a conference call with Benchmark » 11:25
06/14/21
06/14
11:25
06/14/21
11:25
ZBRA

Zebra Technologies

$508.31 /

+0.34 (+0.07%)

Analyst Harrigan holds a…

Analyst Harrigan holds a conference call with Investor Relations at Steele and Sandolval on June 14 at 12 pm hosted by Benchmark.

ShowHide Related Items >><<
ZBRA Zebra Technologies
$508.31 /

+0.34 (+0.07%)

ZBRA Zebra Technologies
$508.31 /

+0.34 (+0.07%)

04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 Morgan Stanley
Zebra downgraded to Underweight from Equal Weight at Morgan Stanley
03/23/21 Northcoast
Zebra Technologies upgraded to Buy from Neutral at Northcoast
02/12/21 Needham
Zebra Technologies price target raised to $515 from $445 at Needham
ZBRA Zebra Technologies
$508.31 /

+0.34 (+0.07%)

ZBRA Zebra Technologies
$508.31 /

+0.34 (+0.07%)

ZBRA Zebra Technologies
$508.31 /

+0.34 (+0.07%)

Recommendations
iTeos deal 'addresses a number of needs all at once, says Piper Sandler » 11:04
06/14/21
06/14
11:04
06/14/21
11:04
ITOS

iTeos Therapeutics

$27.08 /

+7.08 (+35.40%)

, GSK

GlaxoSmithKline

$40.32 /

+0.17 (+0.42%)

Piper Sandler analyst…

Piper Sandler analyst Christopher Raymond is "incrementally positive" on iTeos Therapeutics (ITOS) following the "landmark deal" with GlaxoSmithKline (GSK) for the development of EOS-448, its anti-TIGIT antibody in development for a number of solid tumor indications. The deal, with this partner, "addresses a number of needs all at once," Raymond tells investors in a research note. GSK would appear to be the ideal partner, the deal structure "enables meaningful downstream participation," and iTeos' estimated pro-forma cash now of $930M will result in an acceleration of earlier stage pipeline efforts, says the analyst. Raymond remains a buyer of iTeos Therapeutics with an Overweight rating and $50 price target.

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$27.08 /

+7.08 (+35.40%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

ITOS iTeos Therapeutics
$27.08 /

+7.08 (+35.40%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
ITOS iTeos Therapeutics
$27.08 /

+7.08 (+35.40%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

  • 24
    Jul
ITOS iTeos Therapeutics
$27.08 /

+7.08 (+35.40%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

ITOS iTeos Therapeutics
$27.08 /

+7.08 (+35.40%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

Periodicals
Compugen may see partnership interest after iTeos deal, Dealreporter says » 09:38
06/14/21
06/14
09:38
06/14/21
09:38
CGEN

Compugen

$7.93 /

-0.425 (-5.09%)

, ITOS

iTeos Therapeutics

$20.01 /

+0.11 (+0.55%)

, GSK

GlaxoSmithKline

$40.15 /

-0.07 (-0.17%)

Following the…

Following the collaboration between iTeos Therapeutics (ITOS) and GlaxoSmithKline (GSK), Compugen's (CGEN) anti-TIGIT antibody COM902 could attract large pharma interest as it is yet to be partnered, Dealreporter says. Compugen shares are up 6% to $8.40 in early trading.

ShowHide Related Items >><<
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

CGEN Compugen
$7.93 /

-0.425 (-5.09%)

CGEN Compugen
$7.93 /

-0.425 (-5.09%)

10/14/20 Jefferies
Compugen assumed with a Buy at Jefferies
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
04/30/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,200 GBp at Deutsche Bank
ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

CGEN Compugen
$7.93 /

-0.425 (-5.09%)

  • 24
    Jul
GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

ITOS iTeos Therapeutics
$20.01 /

+0.11 (+0.55%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

GSK GlaxoSmithKline
$40.15 /

-0.07 (-0.17%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.